These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 17785863
1. Postimmunization with IFN-gamma-secreting glioma cells combined with the inducible nitric oxide synthase inhibitor mercaptoethylguanidine prolongs survival of rats with intracerebral tumors. Badn W, Visse E, Darabi A, Smith KE, Salford LG, Siesjö P. J Immunol; 2007 Sep 15; 179(6):4231-8. PubMed ID: 17785863 [Abstract] [Full Text] [Related]
2. Inhibition of inducible nitric oxide synthase enhances anti-tumour immune responses in rats immunized with IFN-gamma-secreting glioma cells. Badn W, Hegardt P, Fellert MA, Darabi A, Esbjörnsson M, Smith KE, Janelidze S, Salford LG, Visse E, Siesjö P. Scand J Immunol; 2007 Mar 15; 65(3):289-97. PubMed ID: 17309784 [Abstract] [Full Text] [Related]
3. Enhanced expression of iNOS intratumorally and at the immunization site after immunization with IFNgamma-secreting rat glioma cells. Johansson AC, Hegardt P, Janelidze S, Visse E, Widegren B, Siesjö P. J Neuroimmunol; 2002 Feb 15; 123(1-2):135-43. PubMed ID: 11880158 [Abstract] [Full Text] [Related]
4. Cure of established, intracerebral rat gliomas induced by therapeutic immunizations with tumor cells and purified APC or adjuvant IFN-gamma treatment. Siesjö P, Visse E, Sjögren HO. J Immunother Emphasis Tumor Immunol; 1996 Sep 15; 19(5):334-45. PubMed ID: 8941873 [Abstract] [Full Text] [Related]
5. Immunization with mutagen-treated (tum-) cells causes rejection of nonimmunogenic rat glioma isografts. Siesjö P, Visse E, Lindvall M, Salford L, Sjögren HO. Cancer Immunol Immunother; 1993 Jul 15; 37(1):67-74. PubMed ID: 8513454 [Abstract] [Full Text] [Related]
6. Effect of inhibition of inducible nitric oxide synthase (iNOS) on the murine splenic immune response induced by Aggregatibacter (Actinobacillus) actinomycetemcomitans lipopolysaccharide. Sosroseno W, Musa M, Ravichandran M, Ibrahim MF, Bird PS, Seymour GJ. Eur J Oral Sci; 2008 Feb 15; 116(1):31-6. PubMed ID: 18186729 [Abstract] [Full Text] [Related]
7. Immunizations with unmodified tumor cells and simultaneous COX-2 inhibition eradicate malignant rat brain tumors and induce a long-lasting CD8(+) T cell memory. Eberstål S, Fritzell S, Sandén E, Visse E, Darabi A, Siesjö P. J Neuroimmunol; 2014 Sep 15; 274(1-2):161-7. PubMed ID: 25022336 [Abstract] [Full Text] [Related]
9. Immunizations with IFNgamma secreting tumor cells can eliminate fully established and invasive rat gliomas. Janelidze S, Bexell D, Badn W, Darabi A, Smith KE, Fritzell S, Gunnarsson S, Milos P, Bengzon J, Salford LG, Siesjö P, Visse E. J Immunother; 2009 Apr 15; 32(6):593-601. PubMed ID: 19483650 [Abstract] [Full Text] [Related]
10. Inhibition of inducible nitric oxide synthase intensifies injury and functional deterioration in autoimmune interstitial nephritis. Gabbai FB, Boggiano C, Peter T, Khang S, Archer C, Gold DP, Kelly CJ. J Immunol; 1997 Dec 15; 159(12):6266-75. PubMed ID: 9550431 [Abstract] [Full Text] [Related]
11. IFNγ in combination with IL-7 enhances immunotherapy in two rat glioma models. Fritzell S, Eberstål S, Sandén E, Visse E, Darabi A, Siesjö P. J Neuroimmunol; 2013 May 15; 258(1-2):91-5. PubMed ID: 23528658 [Abstract] [Full Text] [Related]
12. Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. I. Characterization and in vivo anti-tumor activity of glioma-sensitized lymphocytes. Baldwin NG, Rice CD, Tuttle TM, Bear HD, Hirsch JI, Merchant RE. J Neurooncol; 1997 Mar 15; 32(1):19-28. PubMed ID: 9049859 [Abstract] [Full Text] [Related]
13. Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. II. Cytokine production and in vivo efficacy of glioma-sensitized lymphocytes. Rice CD, Baldwin NG, Biron RT, Bear HD, Merchant RE. J Neurooncol; 1997 Mar 15; 32(1):29-38. PubMed ID: 9049860 [Abstract] [Full Text] [Related]
14. Anticonvulsant-induced suppression of IFN-gamma production by lymphocytes obtained from cervical lymph nodes in glioma-bearing mice. Yamada M, Ohkawa M, Tamura K, Mabuchi E, Kishima H, Tamura M, Shimizu K. J Neurooncol; 2000 Apr 15; 47(2):125-32. PubMed ID: 10982153 [Abstract] [Full Text] [Related]
15. The Selective Acetamidine-Based iNOS Inhibitor CM544 Reduces Glioma Cell Proliferation by Enhancing PARP-1 Cleavage In Vitro. Gallorini M, Maccallini C, Ammazzalorso A, Amoia P, De Filippis B, Fantacuzzi M, Giampietro L, Cataldi A, Amoroso R. Int J Mol Sci; 2019 Jan 24; 20(3):. PubMed ID: 30678338 [Abstract] [Full Text] [Related]
16. Effect of L-N6-(1-iminoethyl)-lysine, an inducible nitric oxide synthase inhibitor, on murine immune response induced by Actinobacillus actinomycetemcomitans lipopolysaccharide. Sosroseno W, Musa M, Ravichandran M, Fikri Ibrahim M, Bird PS, Seymour GJ. J Periodontal Res; 2007 Apr 24; 42(2):124-30. PubMed ID: 17305870 [Abstract] [Full Text] [Related]
17. Glioma-associated hyaluronan induces apoptosis in dendritic cells via inducible nitric oxide synthase: implications for the use of dendritic cells for therapy of gliomas. Yang T, Witham TF, Villa L, Erff M, Attanucci J, Watkins S, Kondziolka D, Okada H, Pollack IF, Chambers WH. Cancer Res; 2002 May 01; 62(9):2583-91. PubMed ID: 11980653 [Abstract] [Full Text] [Related]
18. Antitumor activity against established intracerebral gliomas exhibited by cytotoxic T lymphocytes, but not by lymphokine-activated killer cells. Holladay FP, Heitz T, Wood GW. J Neurosurg; 1992 Nov 01; 77(5):757-62. PubMed ID: 1403119 [Abstract] [Full Text] [Related]
19. Immune rejection of intracerebral gliomas using lymphocytes from glioma-bearing rats. Wood GW, Turner T, Wang YY, Holladay FP. J Immunother; 1999 Nov 01; 22(6):497-505. PubMed ID: 10570748 [Abstract] [Full Text] [Related]
20. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis. Gold DP, Schroder K, Powell HC, Kelly CJ. Eur J Immunol; 1997 Nov 01; 27(11):2863-9. PubMed ID: 9394811 [Abstract] [Full Text] [Related] Page: [Next] [New Search]